Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Advances in Therapy
|
April 19, 2021
A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US
Yiling Jiang, Lori D Bash, Leif Saager
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 26, 2009
Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study
Lori D Bash, Brad C Astor, Josef Coresh
Anesthesia and Analgesia
|
November 16, 2021
Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns
Lori D Bash, Wynona Black, Vladimir Turzhitsky, et al.
Advances in Therapy
|
July 28, 2021
Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings
Lori D Bash, Vladimir Turzhitsky, Wynona Black, et al.
Journal of Managed Care & Specialty Pharmacy
|
August 31, 2017
Changes in Treatment Patterns and Incremental Health Care Utilization Due to P2Y12-Associated Complications in Patients with Acute Coronary Syndrome
Ami Vyas, Lori D Bash, Mehul D Patel, et al.
Archives of Internal Medicine
|
December 10, 2008
Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study
Lori D Bash, Elizabeth Selvin, Michael Steffes, et al.
European Journal of Internal Medicine
|
March 25, 2017
Differences in short and long-term survival between males and females with new-onset heart failure: A retrospective cohort study
Gabriel Chodick, Dahlia Weitzman, Robert O Blaustein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 2, 2010
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study
Kunihiro Matsushita, Elizabeth Selvin, Lori D Bash, et al.
JMIR Perioperative Medicine
|
July 22, 2024
Factors Influencing Neuromuscular Blockade Reversal Choice in the United States Before and During the COVID-19 Pandemic: Retrospective Longitudinal Analysis
Vladimir Turzhitsky, Lori D Bash, Richard D Urman, et al.
Journal of Clinical Anesthesia
|
April 19, 2020
Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials
Amit D Raval, Jennifer Uyei, Andreas Karabis, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Advances in Therapy
|
April 19, 2021
A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US
Yiling Jiang, Lori D Bash, Leif Saager
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 26, 2009
Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study
Lori D Bash, Brad C Astor, Josef Coresh
Anesthesia and Analgesia
|
November 16, 2021
Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns
Lori D Bash, Wynona Black, Vladimir Turzhitsky, et al.
Advances in Therapy
|
July 28, 2021
Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings
Lori D Bash, Vladimir Turzhitsky, Wynona Black, et al.
Journal of Managed Care & Specialty Pharmacy
|
August 31, 2017
Changes in Treatment Patterns and Incremental Health Care Utilization Due to P2Y12-Associated Complications in Patients with Acute Coronary Syndrome
Ami Vyas, Lori D Bash, Mehul D Patel, et al.
Archives of Internal Medicine
|
December 10, 2008
Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study
Lori D Bash, Elizabeth Selvin, Michael Steffes, et al.
European Journal of Internal Medicine
|
March 25, 2017
Differences in short and long-term survival between males and females with new-onset heart failure: A retrospective cohort study
Gabriel Chodick, Dahlia Weitzman, Robert O Blaustein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 2, 2010
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study
Kunihiro Matsushita, Elizabeth Selvin, Lori D Bash, et al.
JMIR Perioperative Medicine
|
July 22, 2024
Factors Influencing Neuromuscular Blockade Reversal Choice in the United States Before and During the COVID-19 Pandemic: Retrospective Longitudinal Analysis
Vladimir Turzhitsky, Lori D Bash, Richard D Urman, et al.
Journal of Clinical Anesthesia
|
April 19, 2020
Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials
Amit D Raval, Jennifer Uyei, Andreas Karabis, et al.
Page
of 7